Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Great excerpt from todays release

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Jan 06, 2014 3:27pm

134 Views

Post# 22062929

RE:Great excerpt from todays release

Strong management has always been one of the great things about NOX. This news release was timely and it would help if they would provide these types of updates a little more often - this is one area that could use some improvement actually. Nice to see buying at these levels, and an increasing share price. Some people are obviously seeing value at these levels (although not everyone agrees and that's just fine - welcome to investing). We've suffered through enough and it's time for this thing to turn around and generate returns for us. - MM

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects